Scott Cormack
2015
In 2015, Scott Cormack earned a total compensation of $839.5K as Former President and Chief Executive Officer at OncoGenex Pharmaceuticals, a 51% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,890 |
|---|---|
| Option Awards | $79,473 |
| Salary | $541,383 |
| Stock Awards | $69,750 |
| Total | $839,496 |
Cormack received $541.4K in salary, accounting for 64% of the total pay in 2015.
Cormack also received $148.9K in non-equity incentive plan, $79.5K in option awards and $69.8K in stock awards.
Rankings
In 2015, Scott Cormack's compensation ranked 8,775th out of 13,638 executives tracked by ExecPay. In other words, Cormack earned more than 35.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,775 out of 13,638 | 36th |
Division Manufacturing | 3,354 out of 5,190 | 35th |
Major group Chemicals And Allied Products | 1,223 out of 1,854 | 34th |
Industry group Drugs | 995 out of 1,528 | 35th |
Industry In Vitro and In Vivo Diagnostic Substances | 41 out of 76 | 46th |
Source: SEC filing on September 21, 2017.
Cormack's colleagues
We found two more compensation records of executives who worked with Scott Cormack at OncoGenex Pharmaceuticals in 2015.